This in-depth focus explores collaborative efforts to accelerate validation and adoption of rapid microbial methods across the pharmaceutical industry and the power of rapid methods for fungal ID.
- A collaborative approach to advancing adoption of RMMs
EPR’s Caroline Peachey explores collaborative efforts to accelerate validation and adoption of rapid microbial methods across the pharmaceutical industry. - The power of rapid methods for fungal ID
By leveraging rapid identification techniques, pharmaceutical facilities can enhance their ability to detect and mitigate fungal contamination, safeguarding product quality and patient safety. Here, Dr Tim Sandle explores key challenges associated with fungal contamination in cleanrooms, discusses conventional and rapid identification methods, as well as the importance of validation.
Download Now
In-depth focus: Microbiology/RMM
Topics
- Analytical and bioanalysis
- Big Pharma
- Bio Products Laboratory Limited (BPL)
- Bioprocessing and biomanufacturing
- Caroline Peachey (European Pharmaceutical Review)
- Drug Development
- Environmental Monitoring
- Formulation and drug delivery
- Quality, microbiology and contamination control
- Rapid Microbiological Methods (RMMs)
- Sterility and rapid methods
- Technology
- Therapeutics
- Tim Sandle (Bio Products Laboratory and University of Manchester)
